7,4'-Dimethoxy-3-hydroxyflavone
7,4'-Dimethoxy-3-hydroxyflavone is an orally active PAR4 antagonist. 7,4'-Dimethoxy-3-hydroxyflavone inhibits PAR4-mediated human platelet aggregation with an IC50 of 1.4 μM. 7,4'-Dimethoxy-3-hydroxyflavone inhibits PAR4-mediated human platelet aggregation and PAR4 signaling pathways, including NF-κB, Ca2+/protein kinase C, Akt, ERK and p38. 7,4'-Dimethoxy-3-hydroxyflavone prevents vascular PAR4 expression, endothelial dysfunction and ameliorates oxidative stress in Streptozotocin (STZ) (HY-13753)-induced diabetic mice. 7,4'-Dimethoxy-3-hydroxyflavone prevents thrombosis in mice without affecting bleeding time[1][2].
For research use only. We do not sell to patients.
- CAS No.: 13198-99-7
- Formula: C17H14O5
- Molecular Weight:298.29
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Calcium Channel Isoforms
More
Biological Activity
Description
IC50 & Target
[1]|
PAR4 |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HL-60 | IC50 |
148 μM
Compound: 7
|
Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
|
[PMID: 25014747] |
In Vitro
7,4'-Dimethoxy-3-hydroxyflavone prevents (DMF-OH) (1-10 μM, 6-48 h) high glucose-induced endothelial PAR4 expression in EA.hy 926 cells[1].
7,4'-Dimethoxy-3-hydroxyflavone (1-10 μM, 6-48 h) prevents high glucose-induced endothelial PAR4 function by abolishing PAR4-mediated Ca2+ responses and reducing Ca2+ responses to AYPGKF-NH₂ (PAR4-activating peptide) or thrombin in EA.hy 926 cells[1].
7,4'-Dimethoxy-3-hydroxyflavone (1-10 μM, 24 h) prevents high glucose-induced PAR4-induced aggravation of endothelial dysfunction in EA.hy 926 cells[1].
7,4'-Dimethoxy-3-hydroxyflavone (1-10 μM, 24 h) prevents high glucose-induced PAR4 expression through inhibition of ROS driven NF-κB activation in EA.hy 926 cells[1].
7,4'-Dimethoxy-3-hydroxyflavone (1-5 μM, 3-5 min) inhibits PAR4-mediated human platelet aggregation and secretion through inhibiting the activation of GPIIb/IIIa, which is the key step for platelet aggregation caused by PAR4-AP[2].
7,4'-Dimethoxy-3-hydroxyflavone (1-5 μM, 1-3 min) inhibits PAR4 downstream signaling pathways, including Ca2+/protein kinase C, Akt, ERK and p38 in platelet[2].
7,4'-Dimethoxy-3-hydroxyflavone (5-20 μM, 10 min) inhibits β-arrestin recruitment to PAR4 concentration-dependently in CHO-K1 cells[2].
7,4'-Dimethoxy-3-hydroxyflavone (5-20 μM, 3 min) enhances the efficacy of Vorapaxar (HY-10119) and Ticagrelor (HY-10064) in inhibiting thrombin-induced platelet aggregation[2].
7,4'-Dimethoxy-3-hydroxyflavone (5-10 μM, 10 min) decreases thrombus formation in whole blood under flow conditions[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:EA.hy926 cells incubated with high glucose (HG)
-
Concentration:1, 3, 10 μM
-
Incubation Time:6 h
-
Result:Inhibited high glucose-induced F2RL3 expression in a concentration-dependent manner, with complete inhibition at 10 μM.
-
Cell Line:EA.hy926 cells incubated with high glucose (HG)
-
Concentration:10 μM
-
Incubation Time:48 h
-
Result:Abolished the high glucose-induced PAR4 protein expression.
-
Cell Line:EA.hy926 cells incubated with high glucose (HG)
-
Concentration:1, 10 μM
-
Incubation Time:24 h
-
Result:Decreased the expression of VCAM1, ICAM1, CCL2, TNF, IL1B and F3
-
Cell Line:EA.hy926 cells incubated with high glucose (HG)
-
Concentration:10 μM
-
Incubation Time:48 h
-
Result:Prevented the ROS production induced by high glucose.
Abolished high glucose-induced NF-κB activation.
In Vivo
7,4'-Dimethoxy-3-hydroxyflavone (DMF-OH) (20 mg/kg, oral gavage, daily for 21 days) prevents vascular PAR4 expression, endothelial dysfunction and ameliorates oxidative stress in Streptozotocin (STZ) (HY-13753)-induced diabetic mice[1].
7,4'-Dimethoxy-3-hydroxyflavone(1-7.5 mg/kg, i.p., single dose) significantly protects from FeCl3-induced carotid arterial occlusions, without significantly affecting tail bleeding time[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:4 weeks male C57BL/6J mice injected STZ (i.p. 180 mg/kg)[1]
-
Dosage:20 mg/kg
-
Administration:Daily by oral gavage for 21 days
-
Result:Did not affect STZ-induced hyperglycaemia and body weight loss.
Blunted the up-regulation of PAR4.
Improved the aortic wall thickening and irregular arrangement of smooth muscle cells of tunica media.
Blunted the increased expression of proinflammatory and procoagulant mediators in the aorta and prevented macrophage infiltration.
Prevented diabetes-induced increases in aortic 8-OHdG levels.
Reduced the increased serum MDA levels.
-
Animal Model:Male Balb/c mice (20-25 g, age 6-8 weeks) model of FeCl3-induced arterial thrombosis[2]
-
Dosage:1, 3, and 7.5 mg/kg
-
Administration:i.p. for 30 min before induction of thrombosis
-
Result:Prevent thrombosis in mice without affecting bleeding time
Chemical Information
-
CAS No. 13198-99-7
-
Molecular Weight 298.29
-
Formula C17H14O5
-
SMILES
COC1=CC=C(C=C1)C2=C(C(C3=CC=C(C=C3O2)OC)=O)O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
-
Ca2+ Staining Technique
Ca2+ staining is an experimental technique that utilizes specific fluorescent probes (such as Fluo-4 AM, Fura-2, etc.) to qualitatively or quantitatively detect dynamic changes in intracellular Ca2+ concentrations; this is achieved by monitoring the changes in fluorescent signals generated when these probes bind to free intracellular calcium ions. The underlying principle relies primarily on the presence of chelating groups within the probe's molecular structure that possess high affinity for calcium ions.
Purity & Documentation
References
[1]. Tsai JY, et al. 7,4'-dimethoxy-3-hydroxyflavone, a protease-activated receptor 4 (PAR4) inhibitor with antioxidant activity, ameliorates diabetic endothelial dysfunction. Br J Pharmacol. 2025 Jun 12. [Content Brief]
[2]. ] Lin YT, et al. Discovery of 7, 4'-dimethoxy-3-hydroxyflavone as a protease-activated receptor 4 antagonist with antithrombotic activity and less bleeding tendency in mice. Biochem Pharmacol. 2022 Aug;202:115152. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)